Patients with abdominal aortic aneurysms should be taking statins regardless of whether you are observing them or planning to repair them Statins Reduce Abdominal Aortic Aneurysm Growth, Rupture, and Perioperative Mortality: A Systemic Review and Meta-Analysis Salata K, Syed M, Hussain MA, de Mestral C, Greco E, Mamdani M, et al. J Am Heart Assoc 2018;7:e008657.
Study design: This study is a retrospective review of Cochrane CENTRAL database, MEDLINE, and Embase through June 15, 2018.
Key findings: Analysis of 22 studies involving 80,428 patients with abdominal aortic aneurysms (AAAs) revealed that statin use is associated with a mean AAA growth rate reduction of 0.82 mm/y (P ¼ .001), lower rupture risk (P < .0001), and lower 30-day mortality after elective AAA repair (P ¼ .005). The crude rupture rate was 34% for statin patients and 47% for control patients. The crude 30-day mortality rate was 1.8% for the statin group and 2.6% for the control group. The largest effect was in patients who underwent open AAA repair as opposed to endovascular aneurysm repair.
Conclusion: Statin use may be associated with reduction in AAA growth, rupture, and perioperative mortality after elective AAA repair.
Commentary: Statins reduce vascular inflammation and can play a key role in the collagenolytic pathway involved in AAA progression. Statins reduce collagen breakdown by stabilizing matrix metalloproteinases and reduce intramural aortic matrix metalloproteinase expression. Overexpression of these collagenases is thought to cause AAA development and progression. The authors' findings did not allow them to suggest specific statins, doses, or minimum duration of therapy required to achieve the suggested benefits of AAA outcome. The study showed that AAAs grow about 1 mm slower per year if a patient takes statins (more slowly for larger aneurysms). I agree with the authors that "current evidence suggests that many vascular surgery patients are not adequately risk factor controlled" and "a substantial missed opportunity may exist for the reduction of mortality following both open and EVAR repair of AAA." Patients with AAAs being observed with serial surveillance studies or being considered for surgery should be taking statins, and we need to have protocols to ensure that they are. Key findings: There were 643 patients with 80% to 99% carotid artery stenosis (one-quarter with history of stroke) who underwent carotid artery stenting (CAS) approximately 1 month before planned coronary artery bypass, cardiac valve surgery, or aortic arch surgery. Clopidogrel (Plavix) was stopped 5 days before heart surgery. The composite outcome of death, stroke, and myocardial infarction (MI) was 26% at 5 years and 47% at 8 years. Independent risk factors for the composite outcome during follow-up included age $80 years, history of stroke, chronic obstructive pulmonary disease, and kidney disease.
Carotid stenting in patients before cardiac surgery

Long-term Results of Carotid Stenting and Risk Factors in Patients With
Conclusion: In this study of CAS followed by cardiac surgery about 1 month later, octogenarians and patients with history of stroke or severe pulmonary or renal disease had higher long-term rates of death, stroke, and MI.
Commentary: There are very few large series of patients or any randomized clinical trials examining the benefits of CAS before heart surgery. I do not think any of us are surprised that age >80 years and history of stroke, chronic obstructive pulmonary disease, or kidney disease were identified as risk factors for death, stroke, or MI after staged CAS and heart surgery.
I am not sure what to conclude from these results. The authors do not offer any helpful recommendations about when or when not to perform CAS before heart surgery. The authors are not vascular surgeons. They opined that "CAS may be even superior to CEA in the context of long-term freedom of death, ipsilateral stroke and myocardial infarction" and "CAS may become the preferred method of obstructive carotid disease treatment in the future." There is abundant literature to the contrary. The reader needs to be aware that the authors excluded unsuccessful CAS
